重大疾病保険の世界市場 (保険契約の種類別、保険料の体系別、保険の補償範囲別)：将来予測 (2025～2030年)

重大疾病保険市場は、2023年に3,669億7,000万米ドルと評価され、2024年には3,987億5,000万米ドルに達すると予測され、CAGR 8.93%で成長し、2030年には6,680億1,000万米ドルに達すると予測されています。

重大疾病保険は、がん、心臓発作、脳卒中などの深刻な健康状態にあると診断された保険契約者に経済的保護を提供するように設計された保障の一種です。重大疾病保険の必要性は、医療コストの上昇と、これらの病気が個人や家族に与える経済的負担によって強調されています。その用途は個人保険と団体保険の両分野にまたがり、従業員の福利厚生パッケージへの付加価値として、また健康上の重大な課題に直面しても経済的安定を求める個人に安心を提供するものです。最終用途の範囲は広く、中高年の個人、高齢者、会社員など様々な層に対応しており、法外な医療費の自己負担に備えることができます。

重大疾病保険市場は、専門的な保険商品の必要性に対する意識の高まり、世界人口の高齢化、生活習慣病の蔓延など、いくつかの成長要因の影響を受けています。さらに、治療や技術の革新は、より幅広い疾病をカバーする保険商品への需要を生み出しています。さまざまな層の特定のニーズに応えるカスタマイズ可能な保険を開発することで、顧客満足度を高め、市場への浸透を図ることがチャンスとなります。

しかし、この市場に課題がないわけではありません。保険料コストの高さ、複雑な商品構造、新興国市場での認知度の低さなどが市場開拓の足かせとなっています。さらに、規制上のハードルは新規市場参入者にとって大きな課題となります。技術革新と研究の主な対象分野としては、一般的でない病気への保障拡大、リスク評価に人工知能を活用すること、低所得者層向けの手ごろなマイクロインシュランス商品の開発などが挙げられます。

市場競争は激しく、保険会社はより多くのシェアを獲得するため、絶えず商品内容を改良しています。この市場を活用しようとする企業にとって、商品の差別化、戦略的パートナーシップ、デジタル・プラットフォームの活用によるアウトリーチと顧客エンゲージメントに注力することが極めて重要です。これらの中核分野に取り組むことで、重大疾病保険分野での事業の大幅な成長と市場でのリーダーシップが期待できます。

市場力学：急速に進化する重大疾病保険市場の主要市場インサイトを公開

重大疾病保険市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 重大疾病保険とその利点の認知度向上
  • 世界の医療サービスと治療費の拡大
  • 慢性疾患の蔓延と老人人口の増加
• 市場抑制要因
  • 重大疾病保険の保険料の高騰
• 市場機会
  • AI技術の導入による保険パッケージの個別化化と保険金請求処理の合理化
  • 医療提供者との戦略的提携による、保険と医療のバンドルパッケージの提供
• 市場の課題
  • 複雑な契約条件に伴う懸念

ポーターのファイブフォース：重大疾病保険市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：重大疾病保険市場における外部からの影響の把握

外部マクロ環境要因は、重大疾病保険市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：重大疾病保険市場における競合情勢の把握

重大疾病保険市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：重大疾病保険市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、重大疾病保険市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：重大疾病保険市場における成功への道筋を描く

重大疾病保険市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

当レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1. 市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2. 市場の発展度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3. 市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4. 競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5. 製品開発・イノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1. 現在の市場規模と今後の成長予測は？

2. 最高の投資機会を提供する製品、セグメント、地域はどこか？

3. 市場を形成する主な技術動向と規制の影響とは？

4. 主要ベンダーの市場シェアと競合ポジションは？

5. ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序論

第2章 分析手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 重大疾病保険とその利点についての認知度向上
    • 世界中で医療サービスと治療のコストが増大
    • 慢性疾患の増加と高齢者人口の増加
  • 抑制要因
    • 重大疾病保険の保険料が高い
  • 機会
    • AI技術を取り入れた保険パッケージの個別化と請求処理の効率化
    • 医療提供者との戦略的連携により、保険と医療をバンドルしたパッケージが提供されます。
  • 課題
    • 複雑な利用規約に関連する懸念
• 市場セグメンテーション分析
  • 保険契約の種類：重篤疾患への費用対効果の高い補償が付いた団体保険の好感度上昇
  • 保険の補償範囲：基本的な適用範囲に対する重大疾病保険の使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的要因
  • 経済的要因
  • 社会的要因
  • 技術的要因
  • 法的要因
  • 環境的要因

第6章 重大疾病保険市場：保険契約の種類別

• 団体保険契約
• 個別保険契約

第7章 重大疾病保険市場：保険料の体系別

• 半年
• 毎月
• 毎四半期
• 毎年

第8章 重大疾病保険市場：保険の適用範囲別

• 基本補償
  • がん
  • 心臓発作
  • 脳卒中
• 包括補償
  • 腎不全
  • 重度の火傷
  • 臓器移植

第9章 南北アメリカの重大疾病保険市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の重大疾病保険市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの重大疾病保険市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析 (2023年)
• FPNVポジショニングマトリックス (2023年)
• 競合シナリオ分析
  • AIAシンガポール、重篤疾患保護ギャップに対処するための新たな提案を発表
  • AXA、引受障壁を下げた新たな重大疾病保険を発表
  • ガーディアンが新しい重大疾病保険従業員福利厚生を発表
• 戦略分析と提言

企業一覧

• Aegon Life Insurance Company Limited
• Aflac Group
• AIA Group Limited
• American International Group
• AmMetLife Insurance Berhad
• Aviva Group
• AWP Health & Life S.A
• Bharti AXA Life Insurance Company Limited
• China Life Insurance (Overseas) Company Limited
• China Pacific Life Insurance (H.K.) Company Limited
• Chubb Group of Insurance Companies
• Future Generali India Insurance Company Limited
• HDFC ERGO General Insurance Company Limited
• ICICI Prudential Life Insurance Co. Ltd.
• Legal & General Group PLC
• Liberty General Insurance Limited
• Manulife Financial
• Max Life Insurance Company Limited
• MetLife, Inc.
• New York Life Insurance Company
• Niva Bupa Health Insurance Company Limited
• Ping An Insurance (Group) Company of China, Ltd.
• Plum Benefits Insurance Brokers Pvt Ltd.
• Policybazaar Insurance Brokers Private Limited
• Prudential Financial, Inc.
• Royal London Group
• Sun Life Inc.
• The Cigna Group Corporation
• The Hospitals Contribution Fund of Australia Ltd.
• The Manufacturers Life Insurance Company
• Tokio Marine Insurance Group
• UnitedHealth Group
• Zurich Group

LIST OF FIGURES

• FIGURE 1. CRITICAL ILLNESS INSURANCE MARKET RESEARCH PROCESS
• FIGURE 2. CRITICAL ILLNESS INSURANCE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CRITICAL ILLNESS INSURANCE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CRITICAL ILLNESS INSURANCE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CRITICAL ILLNESS INSURANCE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CRITICAL ILLNESS INSURANCE MARKET DYNAMICS
• TABLE 7. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY GROUP POLICIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY INDIVIDUAL POLICIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HALF YEARLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MONTHLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY QUARTERLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY YEARLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY HEART ATTACK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY MAJOR BURNS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 72. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 73. CHINA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 77. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 78. INDIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 163. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 164. ITALY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 183. POLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 184. POLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 188. QATAR CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 189. QATAR CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY PREMIUM STRUCTURE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY POLICY COVERAGE, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY BASIC COVERAGE, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM CRITICAL ILLNESS INSURANCE MARKET SIZE, BY COMPREHENSIVE COVERAGE, 2018-2030 (USD MILLION)
• TABLE 235. CRITICAL ILLNESS INSURANCE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 236. CRITICAL ILLNESS INSURANCE MARKET, FPNV POSITIONING MATRIX, 2023

The Critical Illness Insurance Market was valued at USD 366.97 billion in 2023, expected to reach USD 398.75 billion in 2024, and is projected to grow at a CAGR of 8.93%, to USD 668.01 billion by 2030.

Critical illness insurance is a type of coverage designed to offer financial protection to policyholders diagnosed with severe health conditions, such as cancer, heart attack, or stroke. The necessity of critical illness insurance is underscored by rising healthcare costs and the financial burden these illnesses place on individuals and families. Its application spans both personal and group insurance sectors, being a valuable addition to employee benefits packages and offering peace of mind to individuals seeking financial stability in the face of critical health challenges. The end-use scope is extensive, catering to various demographics, including middle-aged individuals, seniors, and corporate employees, thus providing a buffer against exorbitant out-of-pocket medical expenses.

The market for critical illness insurance is influenced by several growth factors, including increasing awareness of the need for specialized insurance products, an aging global population, and the rising prevalence of lifestyle-related diseases. Furthermore, innovations in medical treatments and technologies create a demand for insurance products that cover a wider range of illnesses. An opportunity lies in developing customizable policies that cater to the specific needs of different demographic groups, thus enhancing customer satisfaction and market penetration.

However, the market is not without its challenges. Limitations include high premium costs, complex product structures, and a lack of awareness in developing regions, which hampers market growth. Additionally, regulatory hurdles can pose significant challenges to new market entrants. Key areas for innovation and research include expanding coverage to include less common diseases, utilizing artificial intelligence for risk assessment, and developing affordable micro-insurance products for low-income groups.

The market is highly competitive, with insurers continuously refining their offerings to capture a larger share. For businesses looking to capitalize on this market, it is crucial to focus on product differentiation, strategic partnerships, and leveraging digital platforms for outreach and customer engagement. Addressing these core areas can lead to substantial business growth and market leadership in the critical illness insurance sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Critical Illness Insurance Market

The Critical Illness Insurance Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising awareness about critical illness insurance and its benefits
  • Expanding costs of healthcare services and treatments globally
  • Growing prevalence of chronic illnesses and the increasing geriatric population
• Market Restraints
  • High cost of premiums of critical illness insurance
• Market Opportunities
  • Incorporating AI technologies to personalize insurance packages and streamline claims processing
  • Strategic collaboration with healthcare providers offers bundled insurance and healthcare packages.
• Market Challenges
  • Concerns associated with complex terms and conditions

Porter's Five Forces: A Strategic Tool for Navigating the Critical Illness Insurance Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Critical Illness Insurance Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Critical Illness Insurance Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Critical Illness Insurance Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Critical Illness Insurance Market

A detailed market share analysis in the Critical Illness Insurance Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Critical Illness Insurance Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Critical Illness Insurance Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Critical Illness Insurance Market

A strategic analysis of the Critical Illness Insurance Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Critical Illness Insurance Market, highlighting leading vendors and their innovative profiles. These include Aegon Life Insurance Company Limited, Aflac Group, AIA Group Limited, American International Group, AmMetLife Insurance Berhad, Aviva Group, AWP Health & Life S.A, Bharti AXA Life Insurance Company Limited, China Life Insurance (Overseas) Company Limited, China Pacific Life Insurance (H.K.) Company Limited, Chubb Group of Insurance Companies, Future Generali India Insurance Company Limited, HDFC ERGO General Insurance Company Limited, ICICI Prudential Life Insurance Co. Ltd., Legal & General Group PLC, Liberty General Insurance Limited, Manulife Financial, Max Life Insurance Company Limited, MetLife, Inc., New York Life Insurance Company, Niva Bupa Health Insurance Company Limited, Ping An Insurance (Group) Company of China, Ltd., Plum Benefits Insurance Brokers Pvt Ltd., Policybazaar Insurance Brokers Private Limited, Prudential Financial, Inc., Royal London Group, Sun Life Inc., The Cigna Group Corporation, The Hospitals Contribution Fund of Australia Ltd., The Manufacturers Life Insurance Company, Tokio Marine Insurance Group, UnitedHealth Group, and Zurich Group.

Market Segmentation & Coverage

This research report categorizes the Critical Illness Insurance Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Policy Type, market is studied across Group Policies and Individual Policies.
• Based on Premium Structure, market is studied across Half Yearly, Monthly, Quarterly, and Yearly.
• Based on Policy Coverage, market is studied across Basic Coverage and Comprehensive Coverage. The Basic Coverage is further studied across Cancer, Heart Attack, and Stroke. The Comprehensive Coverage is further studied across Kidney Failure, Major Burns, and Organ Transplant.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising awareness about critical illness insurance and its benefits
    • 5.1.1.2. Expanding costs of healthcare services and treatments globally
    • 5.1.1.3. Growing prevalence of chronic illnesses and the increasing geriatric population
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of premiums of critical illness insurance
  • 5.1.3. Opportunities
    • 5.1.3.1. Incorporating AI technologies to personalize insurance packages and streamline claims processing
    • 5.1.3.2. Strategic collaboration with healthcare providers offers bundled insurance and healthcare packages.
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with complex terms and conditions
• 5.2. Market Segmentation Analysis
  • 5.2.1. Policy Type: Increasing preference for group policies in critical illness for cost-effective coverage
  • 5.2.2. Policy Coverage: Growing usage of critical illness insurance for basic coverage
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Critical Illness Insurance Market, by Policy Type

• 6.1. Introduction
• 6.2. Group Policies
• 6.3. Individual Policies

7. Critical Illness Insurance Market, by Premium Structure

• 7.1. Introduction
• 7.2. Half Yearly
• 7.3. Monthly
• 7.4. Quarterly
• 7.5. Yearly

8. Critical Illness Insurance Market, by Policy Coverage

• 8.1. Introduction
• 8.2. Basic Coverage
  • 8.2.1. Cancer
  • 8.2.2. Heart Attack
  • 8.2.3. Stroke
• 8.3. Comprehensive Coverage
  • 8.3.1. Kidney Failure
  • 8.3.2. Major Burns
  • 8.3.3. Organ Transplant

9. Americas Critical Illness Insurance Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Critical Illness Insurance Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Critical Illness Insurance Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. AIA Singapore launches new proposition to address the critical illness protection gap
  • 12.3.2. AXA unveils new critical illness plan with lower underwriting barriers
  • 12.3.3. Guardian Announces New Critical Illness Insurance Employee Benefit
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aegon Life Insurance Company Limited
• 2. Aflac Group
• 3. AIA Group Limited
• 4. American International Group
• 5. AmMetLife Insurance Berhad
• 6. Aviva Group
• 7. AWP Health & Life S.A
• 8. Bharti AXA Life Insurance Company Limited
• 9. China Life Insurance (Overseas) Company Limited
• 10. China Pacific Life Insurance (H.K.) Company Limited
• 11. Chubb Group of Insurance Companies
• 12. Future Generali India Insurance Company Limited
• 13. HDFC ERGO General Insurance Company Limited
• 14. ICICI Prudential Life Insurance Co. Ltd.
• 15. Legal & General Group PLC
• 16. Liberty General Insurance Limited
• 17. Manulife Financial
• 18. Max Life Insurance Company Limited
• 19. MetLife, Inc.
• 20. New York Life Insurance Company
• 21. Niva Bupa Health Insurance Company Limited
• 22. Ping An Insurance (Group) Company of China, Ltd.
• 23. Plum Benefits Insurance Brokers Pvt Ltd.
• 24. Policybazaar Insurance Brokers Private Limited
• 25. Prudential Financial, Inc.
• 26. Royal London Group
• 27. Sun Life Inc.
• 28. The Cigna Group Corporation
• 29. The Hospitals Contribution Fund of Australia Ltd.
• 30. The Manufacturers Life Insurance Company
• 31. Tokio Marine Insurance Group
• 32. UnitedHealth Group
• 33. Zurich Group